Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: Results of Pediatric AIDS Clinical Trials Study 402 (Q58427262)

From Wikidata
Jump to navigation Jump to search
article
edit
Language Label Description Also known as
English
Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: Results of Pediatric AIDS Clinical Trials Study 402
article

    Statements

    title
    Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402 (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17418382
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17418382%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    28 December 2019
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q58427262&oldid=1955668796"